Diagnostics Platform Value Hurdle offers an end-to-end, API-first diagnostics platform for branded sample collection, certified lab analysis, logistics, and AI-driven biomarker discovery, enabling rapid go-live for partners across digital health, clinics, and pharma.

Saliva Biomarker Innovation Recent launch of a saliva-based DNA methylation biomarker for systemic chronic inflammation positions Hurdle as a partner for aging research and anti-inflammatory diagnostics, appealing to biotech firms and pharma brands focusing on aging and inflammation.

Partner Ecosystem Growth New Partner Phlebotomy Booking Module and redesigned Partner Portal indicate a growing partner-centric approach, suggesting sales opportunities with digital health companies, clinics, and LMS/health platforms seeking turnkey integrations.

Flexible Ordering Advantage Flexible Biomarker Ordering reduces friction in diagnostics, creating a selling point for customers needing customizable, scalable biomarker workflows, including remote patient monitoring and direct-to-consumer programs.

Healthcare Market Fit With at-home tests (HbA1c, Vitamin D) and global lab testing capabilities, Hurdle targets consumer health, chronic disease management, and population health initiatives, presenting opportunities with insurers, employers, and large healthcare systems seeking scalable testing solutions.